CYP2J2 and psoriasis: No significant association was observed between CYP2J2 polymorphism and comorbidity frequency, suggesting that CYP2J2 may increase the risk of developing psoriasis vulgaris, but that it is not associated with an increased risk of cardiovascular comorbidities in psoriasis patients.